Literature DB >> 24080251

Primary bone marrow oedema syndromes.

Sanjeev Patel1.   

Abstract

MRI scanning in patients with rheumatological conditions often shows bone marrow oedema, which can be secondary to inflammatory, degenerative, infective or malignant conditions but can also be primary. The latter condition is of uncertain aetiology and it is also uncertain whether it represents a stage in the progression to osteonecrosis in some patients. Patients with primary bone marrow oedema usually have lower limb pain, commonly the hip, knee, ankle or feet. The diagnosis is one of exclusion with the presence of typical MRI findings. Treatment is usually conservative and includes analgesics and staying off the affected limb. The natural history is that of gradual resolution of symptoms over a number of months. Evidence for medical treatment is limited, but open-label studies suggest bisphosphonates may help in the resolution of pain and improve radiological findings. Surgical decompression is usually used as a last resort.

Entities:  

Keywords:  MRI; bisphosphonates; bone bruising; bone marrow oedema; core decompression; iloprost; oedema; osteoporosis; regional; transient

Mesh:

Year:  2013        PMID: 24080251     DOI: 10.1093/rheumatology/ket324

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  30 in total

Review 1.  Is bone marrow edema syndrome a precursor of hip or knee osteonecrosis? Results of 49 patients and review of the literature.

Authors:  Tobias Geith; Ann-Cathrin Stellwag; Peter E Müller; Maximilian Reiser; Andrea Baur-Melnyk
Journal:  Diagn Interv Radiol       Date:  2020-07       Impact factor: 2.630

2.  Zoledronic acid in nine patients with transient osteoporosis of the hip.

Authors:  Gerasimos Evangelatos; George E Fragoulis; Alexios Iliopoulos
Journal:  Clin Rheumatol       Date:  2019-11-23       Impact factor: 2.980

3.  When brucellosis met the Assessment of SpondyloArthritis international Society classification criteria for spondyloarthritis: a comparative study.

Authors:  Yiwen Wang; Dai Gao; Xiaojian Ji; Jie Zhang; Xiuru Wang; Jingyu Jin; Zheng Zhao; Xiaohu Deng; Chunhua Yang; Jian Zhu; Jianglin Zhang; Feng Huang
Journal:  Clin Rheumatol       Date:  2019-02-26       Impact factor: 2.980

4.  Osteonecrosis of the femoral head: diagnosis and classification systems.

Authors:  Ho-Rim Choi; Marvin E Steinberg; Edward Y Cheng
Journal:  Curr Rev Musculoskelet Med       Date:  2015-09

Review 5.  Transient osteoporosis of the hip: review of the literature.

Authors:  K Asadipooya; L Graves; L W Greene
Journal:  Osteoporos Int       Date:  2017-03-17       Impact factor: 4.507

Review 6.  Bone marrow lesions and subchondral bone pathology of the knee.

Authors:  Elizaveta Kon; Mario Ronga; Giuseppe Filardo; Jack Farr; Henning Madry; Giuseppe Milano; Luca Andriolo; Nogah Shabshin
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-04-13       Impact factor: 4.342

7.  Chinese Guideline for the Diagnosis and Treatment of Osteonecrosis of the Femoral Head in Adults.

Authors: 
Journal:  Orthop Surg       Date:  2017-02       Impact factor: 2.071

Review 8.  [Bone marrow edema and atraumatic necrosis of the femoral head : Therapy].

Authors:  J Beckmann; A Roth; C Niethard; F Mauch; R Best; U Maus
Journal:  Orthopade       Date:  2015-09       Impact factor: 1.087

9.  Bone marrow oedema predicts bone collapse in paediatric and adolescent leukaemia patients with corticosteroid-induced osteonecrosis.

Authors:  Ashok Joseph Theruvath; Preeti Arun Sukerkar; Shanshan Bao; Jarrett Rosenberg; Sandra Luna-Fineman; Sandhya Kharbanda; Heike Elisabeth Daldrup-Link
Journal:  Eur Radiol       Date:  2017-07-19       Impact factor: 5.315

10.  Neridronate for transient osteoporosis of the hip in a child.

Authors:  C Gaggiano; M Bardelli; M Tarsia; S Gentileschi; A Maselli; S Grosso; L Cantarini; B Frediani
Journal:  Osteoporos Int       Date:  2022-02-01       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.